Literature DB >> 2347892

A case of pheochromocytoma producing parathyroid hormone-related protein and presenting with hypercalcemia.

S Kimura1, Y Nishimura, K Yamaguchi, K Nagasaki, K Shimada, H Uchida.   

Abstract

A 54-yr-old man with a left adrenal pheochromocytoma showed mild hypercalcemia and elevated nephrogenous cAMP. Serum levels of PTH and 1,25-dihydroxyvitamin D3 were not elevated. Postoperatively, serum calcium and nephrogenous cAMP declined to normal ranges. Pathologically, the tumor was a benign pheochromocytoma. The clinical findings resembled those of humoral hypercalcemia of malignancy (HHM), and PTH-related protein (PTHrP) immunoreactivity was detected in the tumor extract at a concentration of 80.7 pmol/g wet wt, which is high compared to levels in malignant tumors causing HHM. Production of PTHrP was further confirmed by the demonstration of PTHrP mRNA with Northern blot hybridization analysis. Gel filtration of the extract revealed the presence of at least two different molecules with both immunological and biological activities. One of the peaks appeared close to PTHrP-(1-34), and the other between cytochrome-c and BSA. The latter showed a higher bioactivity to immunoreactivity ratio. These data indicate the multiplicity of PTHrP molecules in pheochromocytoma and support the idea that PTHrP produced by pheochromocytoma causes hypercalcemia in a similar fashion as HHM.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2347892     DOI: 10.1210/jcem-70-6-1559

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Persistent and moderate hypercalcemia related to an ovarian clear cell adenocarcinoma: Pre- and postoperative parathyroid hormone related-peptide and 1,25-dihydroxyvitamin D3 levels.

Authors:  A Benit; J Allard; J Rimailho; J Fauvel; G Escourrou; D Vezzosi; F Donadille; A Bennet; P Caron
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

2.  Pheochromocytoma and paraganglioma.

Authors:  Vitaly Kantorovich; Karel Pacak
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

3.  Parathyroid-hormone-related protein-mediated hypercalcemia in benign congenital mesoblastic nephroma.

Authors:  Tarak Srivastava; Alexander Kats; T John Martin; Suelli Pompolo; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2010-12-15       Impact factor: 3.714

4.  Malignant phaeochromocytoma and hypercalcaemia.

Authors:  J A Bridgewater; W A Ratcliffe; N J Bundred; C W Owens
Journal:  Postgrad Med J       Date:  1993-01       Impact factor: 2.401

5.  Humoral hypercalcemic crisis in a pregnant woman with uterine leiomyoma.

Authors:  Ali Rahil; Fahmi Yousef Khan
Journal:  J Emerg Trauma Shock       Date:  2012-01

6.  Hypercalcemia in pregnancy - a multifaceted challenge: case reports and literature review.

Authors:  Evelyne Rey; Claude-Emilie Jacob; Maral Koolian; Francine Morin
Journal:  Clin Case Rep       Date:  2016-09-17

7.  Metabolic Bone Disease in the Context of Metastatic Neuroendocrine Tumor: Differentiation from Skeletal Metastasis, the Molecular PET-CT Imaging Features, and Exploring the Possible Etiopathologies Including Parathyroid Adenoma (MEN1) and Paraneoplastic Humoral Hypercalcemia of Malignancy Due to PTHrP Hypersecretion.

Authors:  Rohit Ranade; Sandip Basu
Journal:  World J Nucl Med       Date:  2017 Jan-Mar

Review 8.  Hypercalcemic Disorders in Children.

Authors:  Victoria J Stokes; Morten F Nielsen; Fadil M Hannan; Rajesh V Thakker
Journal:  J Bone Miner Res       Date:  2017-11-02       Impact factor: 6.741

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.